Bodisen Biotech (LSE:BODI) Current Deferred Revenue : £0.42 Mil (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Bodisen Biotech's current deferred revenue for the quarter that ended in Jun. 2013 was £0.42 Mil.

Bodisen Biotech Current Deferred Revenue Historical Data

The historical data trend for Bodisen Biotech's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Current Deferred Revenue Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Current Deferred Revenue

Get a 7-Day Free Trial

0.57

1.04

0.36

0.47

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Current Deferred Revenue	Get a 7-Day Free Trial															0.23	0.21	0.42	0.47	0.42

Bodisen Biotech Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.